TLR9 and infection: In the case of infection with the v1.A6 variant, modulation in TLR9 expression was also observed when PBMCs were treated with a high dose of progesterone: receptor expression increased by 1.9 times (p = 0.00331) when cells were infected with v1.A6 (Figure 4A).